[1]李莹莹,蔺晓慧.糖尿病性视网膜病变患者血清中脂肪细胞因子的表达及其影响因素分析[J].眼科新进展,2021,41(1):057-61.[doi:10.13389/j.cnki.rao.2021.0012]
　LI Yingying,LIN Xiaohui.Expression of adipocytokines in the serum of patients with diabetic retinopathy and its factors[J].Recent Advances in Ophthalmology,2021,41(1):057-61.[doi:10.13389/j.cnki.rao.2021.0012]
点击复制

糖尿病性视网膜病变患者血清中脂肪细胞因子的表达及其影响因素分析/HTML
分享到：

《眼科新进展》[ISSN:1003-5141/CN:41-1105/R]

卷:
41卷
期数:
2021年1期
页码:
057-61
栏目:
应用研究
出版日期:
2021-01-05

文章信息/Info

Title:
Expression of adipocytokines in the serum of patients with diabetic retinopathy and its factors
作者:
李莹莹; 蔺晓慧
010000　内蒙古呼和浩特市，内蒙古自治区人民医院眼科
Author(s):
LI Yingying; LIN Xiaohui
Department of Ophthalmology,People’s Hospital of Inner Mongolia Autonomous Region,Huhhot 010000,Inner Mongolia Autonomous Region,China
关键词:
糖尿病性视网膜病变; Apelin; Omentin-1; 糖尿病; 脂肪因子
Keywords:
diabetic retinopathy;  Apelin;  Omentin-1;  diabetes;  adipokine
分类号:
R774.1
DOI:
10.13389/j.cnki.rao.2021.0012
文献标志码:
A
摘要:
目的　研究糖尿病性视网膜病变（DR）患者血清中脂肪细胞因子Apelin及Omentin-1的变化，及其与临床指标间的相关性，探讨Omentin-1及Apelin在DR发生发展中所起的作用，以期用于糖尿病高危人群的筛选、预测、早期诊断。方法　收集2018年11月至2019年11月就诊于我院的2型糖尿病患者，其中合并DR者为DR组，未合并DR(NDR)者为NDR组，同期在我院眼科行白内障手术治疗者及门诊健康体检者作为正常对照组（NC组）。抽取空腹静脉血，分离血清。收集患者体质量指数（BMI）、糖化血红蛋白（HbA1c）、高密度脂蛋白胆固醇（HDL-C）、低密度脂蛋白胆固醇（LDL-C）、总胆固醇（TC）、甘油三酯（TG）、空腹胰岛素（FINS）、空腹血浆葡萄糖（FPG）、超敏CRP（hs-CRP)、胰岛素抵抗指数（HOMA-IR)及TyG指数等临床相关指标；采用ELISA检测血清中Apelin及Omentin-1蛋白浓度。结果　血清中，Apelin蛋白浓度DR组为（57.22±11.28）×10-3 ng?L-1，高于NDR组的（47.00±12.19 ）×10-3 ng?L-1，两组均高于NC组的（29.47±8.89）×10-3 ng?L-1；Omentin-1蛋白浓度DR组为（42.36±7.43）×10-3 ng?L-1，低于NDR组的（52.96±10.69）×10-3 ng?L-1，两组均低于NC组的（62.41±8.87）×10-3 ng?L-1，差异均有统计学意义(均为P<0.05)。血清Apelin水平与糖尿病严重程度、BMI、FPG、HOMA-IR、HbA1c、hs-CRP、TyG指数均呈正相关（均为P<0.05）；血清Omentin-1水平与DM严重程度、病程、BMI、FPG、HOMA-IR、HbA1c、hs-CRP、TyG指数、Apelin均呈负相关（均为P<0.05）。血清Omentin-1的ROC曲线下面积（0.771）大于血清Apelin的ROC曲线下面积（0.739），两者联合诊断时ROC曲线下面积为0.791。结论　Apelin、Omentin-1可能参与DR的发生发展；Apelin、Omentin-1可能在糖脂代谢、胰岛素抵抗方面发挥作用；血清Apelin、Omentin-1可能对是否发生DR起到一定的预测作用。
Abstract:
Objective　To study the changes of serum Apelin and Omentin-1 in patients with diabetic retinopathy, and their correlation with clinical indicators, to explore the role of Omentin-1 and Apelin in the development and development of DR for the high-risk population of diabetes’ screening, prediction, and early diagnosis.Methods　The patients with type 2 diabetes who were admitted to our hospital from November 2018 to November 2019 were collected. Among them, those with DR were in the DR group, and those without DR (non-DR, NDR) were in the NDR group. During the same period, those who underwent cataract surgery in the ophthalmology department of our hospital and those who had physical examination in the outpatient clinic served as the normal control group (NC group). Fasting venous blood was drawn for separating serum. The indicators including body mass index (BMI), glycated hemoglobin (HbA1c), high density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC) , Triglycerides (TG), fasting insulin (FINS), fasting plasma glucose (FPG), hypersensitivity CRP (Oy-CRP) and related insulin resistance index (HG-IRP) were collected. ELISA was used to detect the protein concentration of Apelin and Omentin-1 in serum.Results　In the serum, the Apellin protein concentration in the DR group was (57.22±11.28)×10-3 ng?L-1, which was higher than that of the NDR group ［(47.00±12.19)×10-3 ng?L-1］, and both groups were higher than the NC group ［(29.47±8.89)×10-3 ng?L-1］. The Omintin-1 protein concentration in the DR group was (42.36±7.43)×10-3 ng?L-1, which was lower than the NDR group［(52.96±10.69)×10-3 ng?L-1］, and both groups was lower than the NC group ［(62.41±8.87)×10-3 ng?L-1］, and the differences were statistically significant (all P<0.05). Serum Apelin level was positively correlated with diabetes severity, BMI, FPG, HOMA-IR, HbA1c, hs-CRP, and TyG index (all P<0.05); serum Omintin-1 level was correlated with DM severity, course of disease, BMI , FPGA, HO-MA-IR, HbA1c, hs-CRP, TyG index, and Apelin were all negatively correlated (all P<0.05). The area under the curve of serum Omentin-1 (0.771) was greater than the area under the curve of serum Apelin (0.739), and the area under the curve for the combined diagnosis with serum Omentin-1 and Apelin was 0.791.Conclusion　Apelin and Omentin-1 may be involved in the occurrence and development of DR; Apelin and Omentin-1 may play a role in glucose and lipid metabolism and insulin resistance; serum Apelin and Omentin-1 may play a certain role in predicting the occurrence of DR.

参考文献/References:

［1］　SAEEDI P,SALPEA P,KARURANGE S,PETERSOHN I,MALANDA B,GREGG E W,et al.Mortality attributable to diabetes in 20-79 years old adults,2019 estimates:Results from the International Diabetes Federation Diabetes Atlas,9th edition［J］.Diabetes Res Clin Pract,2020,162:108086.
［2］　史煜,许译丹,丁波,刘媛,陈力迅,陈春生.Apelin-APJ系统基因单核苷酸多态性与糖尿病视网膜病变的关系［J］.眼科新进展,2019,39(12):1157-1161.
SHI Y,XU Y D,DING B,LIU Y,CHEN L X,CHEN C S.Relationship between single nucleotide polymorphism of apelin-APJ system gene and diabetic retinopathy［J］.Rec Adv Ophthalmol,2019,39(12):1157-1161.
［3］　SHAW J E,SICREE R A,ZIMMET P Z.Global estimates of the prevalence of diabetes for 2010 and 2030［J］.Diabetes Res Clin Pract,2010,87(1):4-14.
［4］　蒋凌云.2型糖尿病内脏脂肪、脂肪因子与心脏外膜脂肪及心功能关系研究［D］.南宁：广西中医药大学,2017.
JIANG L Y.Research the relationship between visceral adipose tissue,adipokines and epicardial adipose tissue,cardiac function in Type 2 diabetes mellitus patients［D］.Nanning:Guangxi University of Chinese Medicine,2017.
［5］　KASAI A,ISHIMARU Y,HIGASHINO K,KOBAYASHI K,YAMAMURO A,YOSHIOKA Y,et al.Inhibition of apelin expression switches endothelial cells from proliferative to mature state in pathological retinal angiogenesis［J］.Angiogenesis,2013,16(3):723-734.
［6］　TAN B K,ADYA R,FARHATULLAH S,CHEN J,LEHNERT H,RANDEVA H S.Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome［J］.Diabetes,2010,59(12):3023-3031.
［7］　LI W W,NIU W Q,ZHANG Y,WU S,GAO P J,ZHU D L.Family-based analysis of apelin and AGTRL1 gene polymorphisms with hypertension in Han Chinese［J］.J Hypertens,2009,27(6):1194-1201.
［8］　YASIR M,SENTHILKUMAR G P,JAYASHREE K,RAMESH BABU K,VADIVELAN M,PALANIVEL C.Association of serum omentin-1,apelin and chemerin concentrations with the presence and severity of diabetic retinopathy in type 2 diabetes mellitus patients［J］.Arch Physiol Biochem,2019,1-8.
［9］　李莹莹,蔺晓慧.多因素介导下糖尿病性视网膜病变的发生机制研究［J］.医学综述,2018,24(24):4918-4921，4927.
LI Y Y,LIN X H.Study on pathogenesis of multi-factor-mediated diabetic retinopath［J］.Med Rec,2018,24(24):4918-4921，4927.
［10］　彭安林,焦丽华,陈红，黄昆.新型脂肪因子Apelin在糖尿病并发症中的应用［J］.中国医院药学杂志,2014,34(13):1139-1143.
PENG A L,JIAO L H,CHEN H,HUANG K.The use of new fat factor—Apelin in diabetes complications［J］.Chin J Hosp Pharm,2014,34(13):1139-1143.
［11］　BOUCHER J,MASRI B,DAVIAUD D,GESTA S,GUIGNE C,MAZZUCOTELLI A,et al.Apelin,a newly identified adipokine up-regulated by insulin and obesity［J］.Endocrinology,2005,146(4):1764-1771.
［12］　TAN Y L,ZHENG X L,TANG C K.The protective functions of omentin in cardiovascular diseases［J］.Clin Chim Acta,2015,448:98-106.
［13］　闫配,张晓红,张莉.血清网膜素-1水平与糖尿病视网膜病变的相关性研究［J］.药物生物技术,2018,25(6):493-495.
YAN P,ZHANG X H,ZHANG L.Correlation between serum level of Omentin-1 and diabetic retinopathy［J］.Pharmac Biotechnol,2018,25(6):493-495.
［14］　董钊.脂肪因子Omentin与糖尿病足病的相关性分析［D］.唐山：华北理工大学,2018.
DONG Z.Analysis of correlation between Omentin and diabetic foot disease［D］.Tangshan:North China University of Science and Technology,2018.
［15］　DU J H,LI X,LI R,XU L,MA R R,LIU S F.Elevation of serum apelin-13 associated with proliferative diabetic retinopathy in type 2 diabetic patients［J］.Int J Ophthalmol,2014,7(6):968-973.
［16］　TAO Y,LU Q,JIANG Y R,QIAN J,WANG J Y,GAO L,et al.Apelin in plasma and vitreous and in fibrovascular retinal membranes of patients with proliferative diabetic retinopathy［J］.Invest Ophthalmol Vis Sci,2010,51(8):4237-4242.
［17］　HU H,HE L,LI L,CHEN L.Apelin/APJ system as a therapeutic target in diabetes and its complications［J］.Mol Genet Metab,2016,119(1-2):20-27.
［18］　ELSAID N H,SADIK N A,AHMED N R,FAYEZ S E,MOHAMMED N A E.Serum omentin-1 levels in type 2 diabetic obese women in relation to glycemic control,insulin resistance and metabolic parameters［J］.J Clin Transl Endocrinol,2018,13:14-19.

相似文献/References:

[1]张 洁 孟小妹 张亦农.重度非增殖性与增殖性糖尿病性视网膜病变多焦视网膜电图一阶函数核的特征分析[J].眼科新进展,2008,28(9):000.
[2]陈娟,吕红彬. 抗VEGF药物在糖尿病性视网膜病变治疗中的应用[J].眼科新进展,2014,34(4):397.[doi:10.13389/j.cnki.rao.2014.0110]
[3]李婷婷,胡健艳,吴强.靶向G蛋白偶联受体91的小发夹RNA慢病毒载体的构建及功能初步检测[J].眼科新进展,2014,34(8):705.[doi:10.13389/j.cnki.rao.2014.0193]
　Li Ting-Ting,HU Jian-Yan,WU Qiang.Construction and identification of shRNA lentiviral vector of G protein-coupled receptor 91[J].Recent Advances in Ophthalmology,2014,34(1):705.[doi:10.13389/j.cnki.rao.2014.0193]
[4]陈明,刘志谦,段志辉,等.玻璃体切割联合保留前囊膜的晶状体切除治疗糖尿病性视网膜病变[J].眼科新进展,2014,34(10):956.[doi:10.13389/j.cnki.rao.2014.0265]
[5]陈小红,王云鹏,陈梅珠. VEGF在糖尿病性视网膜病变发病机制中的作用及抗VEGF治疗新进展[J].眼科新进展,2015,35(7):692.[doi:10.13389/j.cnki.rao.2015.0190]
　CHEN Xiao-Hong,WANG Yun-Peng,CHEN Mei-Zhu. Role of VEGF in pathogenesis of diabetic retinopathy and anti-VEGF therapy[J].Recent Advances in Ophthalmology,2015,35(1):692.[doi:10.13389/j.cnki.rao.2015.0190]
[6]向小红,吕红彬.雌激素与糖尿病性视网膜病变的研究进展[J].眼科新进展,2017,37(5):496.[doi:10.13389/j.cnki.rao.2017.0126]
　XIANG Xiao-Hong,LV Hong-Bin.Recent advances in estrogen and diabetic retinopathy[J].Recent Advances in Ophthalmology,2017,37(1):496.[doi:10.13389/j.cnki.rao.2017.0126]
[7]张鹏飞,张杰,高荣玉,等.玻璃体内注射血管内皮生长因子（VEGF）抑制剂治疗糖尿病视网膜病变患者的疗效[J].眼科新进展,2018,38(10):977.[doi:10.13389/j.cnki.rao.2018.0231]
　ZHANG Peng-Fei,ZHANG Jie,GAO Rong-Yu,et al.The efficacy of intravitreal injection of vascular endothelial growth factor （VEGF） inhibitors in patients with diabetic retinopathy[J].Recent Advances in Ophthalmology,2018,38(1):977.[doi:10.13389/j.cnki.rao.2018.0231]
[8]史煜,许译丹,丁波,等.apelin-APJ系统基因单核苷酸多态性与糖尿病视网膜病变的关系[J].眼科新进展,2019,39(12):1157.[doi:10.13389/j.cnki.rao.2019.0266]
　SHI Yu,XU Yi-Dan,DING Bo,et al.Relationship between single nucleotide polymorphism of apelin-APJ system gene and diabetic retinopathy[J].Recent Advances in Ophthalmology,2019,39(1):1157.[doi:10.13389/j.cnki.rao.2019.0266]
[9]许冬,李浩,周利晓,等.基于卷积神经网络UNet构建糖尿病性黄斑水肿自动识别模型[J].眼科新进展,2020,40(4):357.[doi:10.13389/j.cnki.rao.2020.0082]
　XU Dong,LI Hao,ZHOU Lixiao,et al.Model of automatic identification of diabetic macular edema via convolutional neural networks UNet[J].Recent Advances in Ophthalmology,2020,40(1):357.[doi:10.13389/j.cnki.rao.2020.0082]
[10]刘梓煜,刘大川.生物靶向抑制剂在治疗眼底新生血管中的研究进展[J].眼科新进展,2020,40(6):593.[doi:10.13389/j.cnki.rao.2020.0136]
　LIU Ziyu,LIU Dachuan.Research advances on the treatments of fundus neovascularization by bio-targeted inhibitor[J].Recent Advances in Ophthalmology,2020,40(1):593.[doi:10.13389/j.cnki.rao.2020.0136]

备注/Memo

备注/Memo:
内蒙古自治区自然科学基金面上项目（编号：2019MS08084）
更新日期/Last Update: 2021-01-05